von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeMiha Furlan, Bernhard Lämmle, Rodolfo Robles et al.|New England Journal of Medicine|1998Cited by 1.7k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney DiseaseDick de Zeeuw, Glenn M. Chertow, Colin J. Meyer et al.|New England Journal of Medicine|2013Cited by 990
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaPiero Ruggenenti, Giuseppe Remuzzi, Annalisa Perna et al.|The Lancet|1999Cited by 909
Overview of Complement Activation and RegulationMarina Noris, Giuseppe Remuzzi|Seminars in Nephrology|2013Cited by 864
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trialPiero Ruggenenti, Giuseppe Remuzzi, Annalisa Perna et al.|The Lancet|2005Cited by 644